Beatrice (psychedelic)
Appearance
This article relies largely or entirely on a single source. (July 2019) |
Names | |
---|---|
Preferred IUPAC name
1-(2,5-Dimethoxy-4-methylphenyl)-N-methylpropan-2-amine | |
Other names
4-Methyl-2,5-dimethoxy-methamphetamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-alpha,N-methylamine | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C13H21NO2 | |
Molar mass | 223.316 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Beatrice (also known as MDO-D, MDOM, Béa and 4-methyl-2,5-dimethoxymethamphetamine) is a lesser-known psychedelic drug. It is a substituted methamphetamine and a homolog of 2,5-dimethoxy-4-methylamphetamine (DOM). Beatrice was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 30 mg, and the duration listed as 6–10 hours.[1] Beatrice produces a vague feeling of openness and receptiveness, and causes a stimulative effect. It also causes diarrhea. Very little data exists about the pharmacological properties, metabolism, and toxicity of beatrice.
Legal Status
In the US, this substance is a Schedule I isomer of DOET.
See also
- 4-Methylmethamphetamine
- Phenethylamine
- Psychedelics, dissociatives and deliriants
- Ganesha (psychedelic)
External links
References